Your browser doesn't support javascript.
loading
The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures.
Kraus, Michael S; Gold, James M; Barch, Deanna M; Walker, Trina M; Chun, Charlotte A; Buchanan, Robert W; Csernansky, John G; Goff, Donald C; Green, Michael F; Jarskog, L Fredrik; Javitt, Daniel C; Kimhy, David; Lieberman, Jeffrey A; McEvoy, Joseph P; Mesholam-Gately, Raquelle I; Seidman, Larry J; Ball, M Patricia; Kern, Robert S; McMahon, Robert P; Robinson, James; Marder, Stephen R; Keefe, Richard S E.
Afiliación
  • Kraus MS; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States of America.
  • Gold JM; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Barch DM; Department of Psychiatry, Washington University in St. Louis School of Medicine, St. Louis, MO, United States of America.
  • Walker TM; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States of America.
  • Chun CA; Temple University, Philadelphia, PA, United States of America.
  • Buchanan RW; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Csernansky JG; Department of Psychiatry, Northwestern Feinberg School of Medicine, Chicago, IL, United States of America.
  • Goff DC; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, United States of America.
  • Green MF; UCLA Semel Institute for Neuroscience and Human Behavior, United States of America.
  • Jarskog LF; VA VISN 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, CA, United States of America.
  • Javitt DC; North Carolina Psychiatric Research Center, Department of Psychiatry, University of North Carolina at Chapel Hill, United States of America.
  • Kimhy D; Department of Psychiatry, Nathan Kline Institute for Psychiatric Research, New York University School of Medicine, New York, NY, United States of America.
  • Lieberman JA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
  • McEvoy JP; Department of Psychiatry, New York State Psychiatric Institute and College of Physicians and Surgeons, Columbia University, United States of America.
  • Mesholam-Gately RI; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, United States of America.
  • Seidman LJ; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
  • Ball MP; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, United States of America.
  • Kern RS; Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
  • McMahon RP; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Robinson J; UCLA Semel Institute for Neuroscience and Human Behavior, United States of America.
  • Marder SR; VA VISN 22 Mental Illness Research, Education, and Clinical Center, Los Angeles, CA, United States of America.
  • Keefe RSE; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, United States of America.
Schizophr Res Cogn ; 19: 100161, 2020 Mar.
Article en En | MEDLINE | ID: mdl-31832342

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Schizophr Res Cogn Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Schizophr Res Cogn Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos